Catalyst Pharmaceuticals

Catalyst Pharmaceuticals: Catalyst Pharmaceuticals is a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases. With exceptional patient focus, Catalyst is committed to developing a robust pipeline of cutting-edge, best-in-class medicines for rare diseases. Catalyst's New Drug Application for FIRDAPSEĀ® (amifampridine) Tablets 10 mg for the treatment of adults with Lambert-Eaton myasthenic syndrome ("LEMS") was approved in 2018 by the U.S. Food & Drug Administration ("FDA") and FIRDAPSE is commercially available in the United States as a treatment for adults and children ages six to seventeen with LEMS. Further, Canada's national healthcare regulatory agency, Health Canada, has approved the use of FIRDAPSE for the treatment of adult patients in Canada with LEMS.
Based in...
US - South Atlantic
Clinical Stage
Phase III, Phase l or ll
Disease Space
Rare Disease
Public, USA
Market Cap
1B +
Therapeutic Modalities
Small Molecule
355 Alhambra Circle
Suite 801
Coral Gables, FL 33134
United States

Company Participants at Solebury Trout 1x1 Management Access Event 2022

  • Jeff Del Carmen, CCO
  • Mary Coleman, Vice President, Investor Relations
  • Patrick J McEnany, Chairman/President/CEO/Co-Founder
  • Steven Miller, Chief Operating Officer & Chief Scientific Officer

Top 10 Holders of Catalyst Pharmaceuticals, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
BlackRock Fund Advisors 10.68 11,323,870 132.38 13F 6/30/23
State Street Corp. 8.91 9,453,077 110.51 13F 6/30/23
Deerfield Management Co. LP 7.72 8,192,000 95.76 13F 6/30/23
Vanguard Group, Inc. (Subfiler) 6.23 6,611,102 77.28 13F 6/30/23
BlackRock Institutional Trust Co. NA 2.82 2,986,589 34.91 13F 6/30/23
Dimensional Fund Advisors LP 2.33 2,472,410 28.90 13F 6/30/23
The Vanguard Group, Inc. 1.89 2,012,353 23.52 Funds 8/31/23
Geode Capital Management LLC 1.82 1,926,415 22.52 13F 6/30/23
Jacobs Levy Equity Management, Inc. 1.25 1,321,281 15.45 13F 6/30/23
Invesco Capital Management LLC 1.14 1,210,264 14.15 13F 6/30/23
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.